Target intelligence / Profile preview

CAMTA1 antisense RNA 2 (CAMTA1-AS2)

Target: CAMTA1-AS2
Molecular classification: Long non-coding RNA (lncRNA)

Overview

CAMTA1 antisense RNA 2 (CAMTA1-AS2) is presumably a long non-coding RNA transcribed from the antisense strand of the CAMTA1 locus. There are currently no experimentally validated reports or functional studies describing CAMTA1-AS2 in the biomedical literature or major gene/protein databases. This distinguishes it from CAMTA1, a calmodulin-binding transcription activator with known CNS and tumor suppressor functions. Information on CAMTA1-AS2 may be absent due to it being a predicted transcript, having limited tissue expression, or being misnamed. To date, "CAMTA1-AS2" is not established as a therapeutic target, biomarker, or disease-related gene.

Beyond the preview

Go deeper on CAMTA1 antisense RNA 2 (CAMTA1-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CAMTA1 antisense RNA 2 (CAMTA1-AS2).

Explore the full profile